Development of bio-marine skin products.

 Mar 23rd 2019

Annual rep. 18 (unaudited)

Mar 13th 2019

Patent annuities 2019 paid

     Dec 19 th 2018
EPO patent granted

 

 

Regenics AS is a private Norwegian biotechnology company based in Oslo. The business concept is to develop and patent marine technologies and products from salmon roe for therapeutic and cosmetic applications.

Wound Healing - Skin diseases

Regenics is developing several products for therapeutic skin applications. The most advanced is VERNEX® for  wound healing. Line extension development involve devices for topical psoriasis and atopic dermatitis. The technology may have the capacity to support living cells in future artificial 3D-skin skin (COLLEX®.)

Vernex® - medical device for wound healing

VERNEX® is a medical device under development using an active marine ingredient extracted from salmon roe without using organic solvents, additions or preservatives and are therefore purely natural products. Regenics’ idea is to locally revive the regenerative abilities of skin cells for therapeutic purposes.

News

Regenics AS has developed a number of assays and techniques to study effects of various substances on skin cells both in vitroin vivo and in the clinic. Our focus is to develop products and techniques for therapeutic skin applications and to improve skin appearance.


klima, energi National news cheap fjallraven backpack Adidas Ncs Danmark cheap swiss gear backpack Golden State Warriors Jerseys European News Web Tennessee Titans Jerseys Baseball cheap hydro flask